Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
11.49
+0.02 (0.17%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $166.04 million as of April 17, 2025.
Market Cap
166.04M
Enterprise Value
21.49M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.49
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has decreased from $198.24M to $166.04M, a decrease of -16.24%. That is a compound annual growth rate of -18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 166.04M | -25.52% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.22B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.41B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |